Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Kineret“
Suchtreffer
Begriffe & Kennungen
Kineret · 4.8 · Adverse events data in patients with FMF are based on post-marketing adverse event reports and published studi
Eintrag öffnenKineret · 4.8 · Adverse events data in patients with Still’s disease is based on a partially open-label and partially blinded,
Eintrag öffnenKineret · 4.8 · Adverse reactions data in CAPS patients are based on an open-label study of 43 patients with NOMID/CINCA treat
Eintrag öffnenKineret · 4.8 · Allergic reactions Allergic reactions including anaphylactic reactions, angioedema, urticaria, rash, and pruri
Eintrag öffnenKineret · 4.8 · Blood cholesterol increase In clinical studies of RA, 775 patients treated with daily Kineret doses of 30 mg,
Eintrag öffnenKineret · 4.8 · Drug reaction with eosinophilia and systemic symptoms (DRESS) During post-marketing use, drug reaction with eo
Eintrag öffnenKineret · 4.8 · During post-marketing use isolated case reports indicating non-infectious hepatitis have been received. Hepati
Eintrag öffnenKineret · 4.8 · During post-marketing use of Kineret, thrombocytopenia has been reported, including occasional case reports in
Eintrag öffnenKineret · 4.8 · Immunogenicity In clinical studies in RA, up to 3% of adult patients tested seropositive at least once during
Eintrag öffnenKineret · 4.8 · In RA patients the most common and consistently reported treatment-related adverse reactions associated with K
Eintrag öffnenKineret · 4.8 · In a study with 12 FMF patients treated 4 months with Kineret in a published randomized controlled study no al
Eintrag öffnenKineret · 4.8 · In a study with 15 SJIA patients followed for up to 1.5 years, no allergic event was serious and no event requ
Eintrag öffnenKineret · 4.8 · In a study with 15 SJIA patients followed for up to 1.5 years, one event of transient neutropenia was reported
Eintrag öffnenKineret · 4.8 · In a study with 15 SJIA patients followed for up to 1.5 years, one patient developed a serious hepatitis in co
Eintrag öffnenKineret · 4.8 · In a study with 15 SJIA patients followed for up to 1.5 years, the most common and consistently reported treat
Eintrag öffnenKineret · 4.8 · In a study with 43 CAPS patients followed for up to 5 years neutropenia was reported in 2 patients. Both episo
Eintrag öffnenKineret · 4.8 · In a study with 43 CAPS patients followed for up to 5 years no patient permanently or temporarily discontinued
Eintrag öffnenKineret · 4.8 · In a study with 43 CAPS patients followed for up to 5 years the frequency of serious infections was 0.1/year,
Eintrag öffnenKineret · 4.8 · In a study with 43 CAPS patients followed for up to 5 years, no allergic event was serious and no event requir
Eintrag öffnenKineret · 4.8 · In clinical studies and during post-marketing use, rare cases of opportunistic infections have been observed a
Eintrag öffnen